A novel human malignant fibrous histiocytoma cell line of the heart (MFH-H) with secretion of hematopoietic growth factors

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1901-1907

  Reinecke, Petra ^a   Moll, Roland ^b   Hildebrandt, Barbara ^a   Schmitz, Michael ^a   Schneider, Eva M ^b   Koldovsky, Pavel ^a   Schardt, Cordula ^a   Gabbert, Helmut E ^a   Gerharz, Claus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Hematopoietic growth factors; Malignant fibrous histiocytoma; Multidirectional differentiation; Tumors of the heart

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKERATIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; GENE ACTIVATION; GENE EXPRESSION; HEART; HEART TUMOR; HUMAN; HUMAN CELL; IMMUNOMODULATION; KARYOTYPE; MALIGNANT FIBROUS HISTIOCYTOMA; NEUROFILAMENT; PLASTICITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION;

ADULT; ANIMALS; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART NEOPLASMS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KARYOTYPING; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, NUDE; MUSCLE PROTEINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0032811939     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. O'Brien JE, and Stout AP: Malignant fibrous xanthomas. Cancer 17: 1445-1455, 1964.
2. Weiss SW, and Enzinger FM: Malignant fibrous histiocytoma An analysis of 200 cases. Cancer 41: 2250-2266, 1978.
3. Enziger FM, and Weiss SW: Soft Tissue Tumors, 3rd ed., C.V.Mosby, St. Louis, Chapter 11, 1995.
4. AFIP Tumors of the cardiovascular system. Editors: H.A. McAllister and J.J. Fenoglio, pp 95-99, 1978.
5. Laya MB, Mailliard JA, Bewtra C, Levin HS: Malignant fibrous histiocytoma of the heart A case report and review of the literature. Cancer 59: 1026-1031, 1987.
6. Korbmacher B, Doering C, Schulte HD, Hort W: Malignant fibrous histiocytoma of the heart - Case report of a rare left-atrial tumor. Thorac Cardiovasc Surgeon 40: 303-307, 1992.
7. Wahba A, Liebold A, Birnbaum DE: Recurrent malignant fibrous histiocytoma of the left atrium in a 27-year-old male. Eur J Cardiothorac Surg 7: 387-389, 1993.
8. Di Persio JF, Brennan JK, Lichtman MA, Speiser BL: Human cell lines that elaborate colony-stimulating activity for the marrow cells of man and other species. Blood 51: 507-519, 1978.
9. Di Persio JF, Brennan JK, Lichtman MA, Abboud CN, Kirckpatrick FH: The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT. Blood 56: 717-727, 1980.
10. Iwasaki H, Isayama T, Johzaki H, Kikichi M: Malignant fibrous histiocytoma Evidence of perivascular mesenchymal cell origin Immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 28: 528-537, 1987.
11. Roholl PJM, Prinsen I, Rademakers PHM, Hsu S-M, van Unnik JAM: Two cell lines with epithelial cell-like characteristics established from malignant fibrous histiocytomas. Cancer 8: 1963-1972, 1991.
12. Liesveld JL, Rush S, Kempski MC, Turner AR, Brennan JK, Gasson JC, Abboud CN Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Exp Hematol 21: 1342-1352, 1993.
13. Moll R, Zimbelmann R, Goldschmidt MD, Keith M, Lauffer J, Kasper M, Koch PJ, Franke WW: The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 53: 75-93, 1993.
14. Vindeløv L, Christensen IJ, Nissen NJ: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
15. Vindeløv L, Christensen IJ, Nissen NJ: Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry 5: 328-331, 1983.
16. Reinecke P, Corvin J, Gabbert HE, and Gerharz CD: Anti-proliferative effects of paclitaxel (Taxol®) on human renal clear cell carcinomas in vitro. Eur J Cancer 33: 1122-1129, 1997.
17. Gerharz C-D, Hildebandt B, Moll R, Ramp U, Sarbia M, Storkel S, Koldovsky P, and Gabbert HE: Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines. BrJ Cancer 74: 1605-1614, 1996.
18. Seabright M: A rapid banding technique for human chromosomes. Lancet i: 971-972, 1971.
19. Mitelman F (Ed): Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetics Nomenclature. Basel, S. Karger, 1991.
20. Lawson CW, Fisher C, Gatter KC: An immunohistochemical study of differentiation in malignantfibroushistiocytoma. Histopathol 11: 375-383, 1987.
21. Burke AP, Cowan D, Virmani R: Primary sarcomas of the heart. Cancer 69: 387-395, 1992.
22. Miettinen M, Rapola J: Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Am J Surg Pathol 13(2): 120-132, 1989.
23. Miettinen M, Soini Y: Malignant fibrous histiocytoma Heterogenous patterns of intermediate filament proteins by immunohistochemistry. Arch Pathol Lab Med 113: 1363-1366, 1989.
24. Fletcher CDM: Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16(3): 213-228, 1992.
25. Örndal C, Mandahl N, Rydholm A, Willén H, Brosjö O, Hein S, and Mitelman F: Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 60: 170-175, 1992.
26. Aspberg F, Mertens F, Bauer HCF, Lindholm J, Mitelman F, Mandahl N: Nearhaploidy in two malignant fibrous histiocytomas. Cancer Genet Cytogenet 79: 119-122, 1995.
27. Mandahl N, Heim S, Kristofferson U, Mitelman F, Rooser, B, Rydholm A, and Willen H: Telomeric association in a malignant fibrous histiocytoma. Hum Genet 71: 321-324, 1985.
28. Sieff CA, Niemeyer CM, Mentzer SJ, Faller DV: Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells. Blood 72: 1316-1323, 1988.
29. Slack JL, Nemunaitis J, Andrews DF, Singer JW: Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood 75: 2319-2327, 1990.
30. Lang SH, Miller WR, Duncan W, Habib FK: Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 59: 235-241, 1994.
31. Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T, and Amano Y Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55: 3438-3443, 1995.
32. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, and DiPersio JF Non hematopoietic tumor cells express functional GM-CSF receptors. Blood 73: 1033-1037, 1989.
33. Sanda MG, Bolton E, Mule JJ, Rosenberg SA: In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J Immunoth 12: 132-137, 1992.
34. Masucci G, Ragnhammer P, Wersal, P, Mellstedt H: Granulocyte-macrophage colony-stimulating factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAB 17-1A). Cancer Immunol Immunother 1: 231-235, 1990.
35. Young MRI, Halpin J, Hussain R, Lozano Y, Djordjevic A, Devata S, Matthews JP, and Wright MA Inhibition of tumor production ∼of granulocyte-macrophage colony- stimulating factor by 1-alpha,25-Dihydoxy-vitamin D3 reduces tumor motility and metastasis. Invasion Metastasis 13: 169-177, 1993.